CRWOF(CRWOF)
CRWOF
No analyst ratings available
No analyst price targets available for CRWOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.05T | $982.65B | $983.47B |
| Low | $999.99B | $919.25B | $927.82B |
| High | $1.17T | $1.09T | $1.09T |
| EBITDA Avg | $84.75B | $79.24B | $79.31B |
| Low | $80.64B | $74.13B | $74.82B |
| High | $94.72B | $87.89B | $88.30B |
| EBIT Avg | $55.75B | $52.13B | $52.17B |
| Low | $53.05B | $48.77B | $49.22B |
| High | $62.32B | $57.82B | $58.09B |
| Net Income Avg | $22.35B | $21.97B | $22.22B |
| Low | $20.71B | $20.35B | $20.59B |
| High | $25.64B | $25.21B | $25.50B |
| EPS Avg | $0.91 | $0.89 | $0.90 |
| Low | $0.84 | $0.83 | $0.84 |
| High | $1.04 | $1.02 | $1.04 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 |